OSE Oncology Services Europe S.a.r.l.

OSE Oncology Services Europe S.a.r.l. is a full service CRO specialised in clinical trials in Oncology within the European Union:

► Phase I (ICH-GCP) – first-in-men (clinical toxicity)) dose-escalation-trials

► Phase II (ICH-GCP) – Dose-finding-studies and efficacy studies (proof of concept)

► Phase III (ICH-GCP) – efficacy and safety studies (confirmative; pivotal studies)

► Phase IV (ICH-GCP) – Post-Marketing-Surveillance Studies (PMS)

► Non-industrial Studies -Investigator Initiated Studies (IIT)

Clinical drug development – especially in Oncology – is a very complex business. To be successful, the integration of different expertises and experiences is required. OSE meets these requirements through its powerful team which has the skills and the knowledge to execute clinical studies with high efficency.

As a client of OSE you can exspect

► Professional Project Management and execution of the studies

► Interdisciplinary consulting competence regarding the clinical development of anticancer drugs

Our Toolkit is cutting-edge technology, including an innovative Electronic Data Capture System. This ensures that we have access to information relating to our client’s projects at any time. Cornerstones of our business are operational strength and integrity. We have been co-operating with many of our clients for many years now. This has been the basis for successful, professional relationships, of which we are justifiably proud.